Benjamin Besse MD, PhD a, Koichi Goto MD, PhD b, Yongsheng Wang MD c, Se-Hoon Lee MD, PhD d, Melina E. Marmarelis MD e, Yuichiro Ohe MD, PhD f, Reyes Bernabe Caro MD g, Dong-Wan Kim MD, PhD h, Jong-Seok Lee MD, PhD h, Sophie Cousin MD, MSc i, Eiki Ichihara MD, PhD j, Yongsheng Li MD, PhD k, Luis Paz-Ares MD, PhD l, Akira Ono MD, PhD m, Rachel E. Sanborn MD n, Naohiro Watanabe MD o, Maria Jose de Miguel MD, PhD p, Carole Helissey MD, PhD q, Catherine A. Shu MD r, Alexander I. Spira MD, PhD s, Pascale Tomasini MD, MSc t, James Chih-Hsin Yang MD, PhD u, Yiping Zhang MD v, Enriqueta Felip MD, PhD w, Frank Griesinger MD, PhD x, Saiama N. Waqar MD y, Antonio Calles MD z, Joel W. Neal MD, PhD aa, Christina S. Baik MD, MPH bb, Pasi A. Jänne MD, PhD cc, S. Martin Shreeve MD, PhD dd, Joshua C. Curtin PhD ee, Bharvin Patel PhD ee, Michael Gormley PhD ee, Xuesong Lyu PhD ff, Jun Chen MD, MSc ee, Pei-Ling Chu PhD gg, Janine Mahoney BSN, RN ee, Leonardo Trani MD ee, Joshua M. Bauml MD ee, Meena Thayu MD, MSCE ee, Roland E. Knoblauch MD, PhD ee, Byoung Chul Cho MD, PhD hh
aParis-Saclay University, Institut Gustave Roussy, Villejuif, France
bNational Cancer Center Hospital East, Kashiwa, Japan
cInstitute of Clinical Trial Center and Cancer Center, West China Hospital, Sichuan University, Chengdu, China
dSamsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
eUniversity of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States
fNational Cancer Center Hospital, Tokyo, Japan
gHospital Universitario Virgen Del Rocio, Seville, Spain
hSeoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea
iInstitut Bergonié, Bordeaux, France
jCenter for Clinical Oncology, Okayama University Hospital, Okayama, Japan
kChongqing University Cancer Hospital, Chongqing, China
lHospital Universitario 12 de Octubre, Madrid, Spain
mShizuoka Cancer Center, Shizuoka, Japan
nEarle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, United States
oDepartment of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
pSTART Madrid-CIOCC, Hospital HM Sanchinarro, Madrid, Spain
qClinical Research unit, Military Hospital Begin, Saint‐Mandé, France
rColumbia University Medical Center, New York, NY, United States
sVirginia Cancer Specialists, Fairfax, VA, United States
tAix Marseille University - CNRS, INSERM, CRCM; CEPCM - AP-HM Hopital de La Timone, Marseille, France
uNational Taiwan University Cancer Center, Taipei, Taiwan
vZhejiang Cancer Hospital, Hangzhou, China
wMedical Oncology Service, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital Campus, Universitat Autonoma de Barcelona Barcelona, Spain
xPius-Hospital, University Medicine of Oldenburg, Oldenburg, Germany
yDivision of Oncology, Washington University School of Medicine, St. Louis, MO, United States
zHospital General Universitario Gregorio Marañón, Madrid, Spain
aaStanford University Medical Center, Stanford, CA, United States
bbUniversity of Washington, Fred Hutchinson Cancer Center, Seattle, WA, United States
ccLowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA, United States
ddJanssen Research & Development, San Diego, CA, United States
eeJanssen Research & Development, Spring House, PA, United States
ffJanssen Research & Development, Shanghai, China
ggJanssen Research & Development, Raritan, NJ, United States
hhDivision of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
Corresponding Author : Byoung Chul Cho, MD, PhD